Mesenchymal Cells From Autologous Bone Marrow (MACT)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Mesenchymal Cells From Autologous Bone Marrow (MACT), covering 2022-04-06 to 2022-04-06. Get the full timeline:
Most recent: Clinical Trial Update: Mesenchymal Cells From Autologous Bone Marrow, Administered Intravenously in Patients Diagnosed With Multiple Sclerosis [Phase 1, Phase 2]